Answers are grounded in this paper and cite their sources.
Background Visual impairment affects over 2.2 billion people globally, posing significant challenges in medication management due to difficulties in reading labels, identifying drugs, and following instructions. This affects adherence and potentially increases the risk of medication errors. Assessing the effectiveness of available interventions is essential to improve medication safety for this population.Methods A systematic literature search was conducted in PubMed, Scopus, Embase, International Pharmaceutical Abstract, and Google Scholar following the PRISMA 2020 guidelines. A PROSPERO protocol was registered before the search (CRD420250649876). Studies were screened and evaluated by independent reviewers. Data was extracted into a standardised table, and study quality was assessed using study design-specific tools.Results From 2,112 identified records, seven studies met the inclusion criteria. These studies were conducted in the United States, India, Switzerland, and Thailand. Interventions included AI-powered mobile applications, tactile aids like Braille labels and 3D-printed adaptors, and wireless Radio Frequency Identification (RFID)-based systems. These interventions demonstrated improvements in medication identification, independence, and/or user satisfaction, although study quality and sample sizes varied.Conclusion A range of innovative and accessible interventions can significantly support medication management in visually impaired populations. However, more robust, large-scale research is needed to validate long-term outcomes and scalability. Incorporating these tools into routine pharmacy practice, alongside regulatory support, could promote safer, more inclusive healthcare delivery.
No takes yet. Share an insight, caveat, or question.
Habibullah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: